Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

被引：0

作者：

Nakayama, Izuma

Ohashi, Manabu

Mizusawa, Junki

Kawachi, Hiroshi

Hashimoto, Tadayoshi

Kita, Ryosuke

Kurokawa, Yukinori

Boku, Narikazu

Terashima, Masanori

Fukuda, Haruhiko

Yoshikawa, Takaki

机构：

[1] Japanese Fdn Canc Res, Canc Inst Hosp, Koto Ku, Tokyo, Japan

[2] Natl Canc Ctr, Japan Clin Oncol Grp, Operat Off, Data Ctr, Chuo Ku, Tokyo, Japan

[3] Japanese Fdn Canc Res, Tokyo, Japan

[4] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Translat Res Support Off, Kashiwa, Japan

[5] Osaka Univ, Suita, Japan

[6] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Minato City, Tokyo, Japan

[7] Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan

[8] Natl Canc Ctr, JCOG Data Ctr, Tokyo, Japan

[9] Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

613-225-2575-3984; 298-145-222-184-1022-9126; 261-566-148-2649; 261-566-9690; 261-566-148-454; 261-492-2769; 613-4678-146-2641; 4; 3; 2; 239; 256; 1704; 54; 2861; 193; 62; 5; 1;

D O I：

10.1200/JCO.2024.42.3_suppl.TPS418

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：TPS418 / TPS418

页数：1